Court Approves Merger of Two Pharmaceutical Companies, Pfizer and BioNTech, in Historic Deal Worth Over $68 Billion

Summary

The US District Court for the District of Columbia has approved the proposed merger between Pfizer Inc. and BioNTech SE, a German biotechnology company, in a deal valued at approximately $68 billion, marking a significant development in the pharmaceutical industry